Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials
Jenny Furlanetto, Frederik Marmé, Sabine Seiler, et al.
European Journal of Cancer (2021) Vol. 152, pp. 193-203
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement
Wanda Cui, Rodney P. Rocconi, Ramya Thota, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 10, pp. e415-e423
Open Access | Times Cited: 14
Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B
Frederik Marmé, Miguel Martín, Michael Untch, et al.
ESMO Open (2024) Vol. 9, Iss. 6, pp. 103466-103466
Open Access | Times Cited: 4
Comparison of Oncological Outcomes of Premenopausal with Ovarian Function Suppression Versus Postmenopausal Women in Er+/Her2- Breast Cancer
Min Jung Lee, Ji-Jung Jung, Jong-Ho Cheun, et al.
(2025)
Closed Access
Comparison of Oncological Outcomes of Premenopausal with Ovarian Function Suppression versus Postmenopausal Women in ER+/HER2- Breast Cancer
Min Jung Lee, Ji-Jung Jung, Jong-Ho Cheun, et al.
The Breast (2025), pp. 104449-104449
Open Access
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers
Tao Qing, Thomas Karn, Mariya Rozenblit, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 13
The effects and mechanism of taxanes on chemotherapy-associated ovarian damage: A review of current evidence
Chuqing Wu, Tong Wu, Dan Chen, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 10
Maximizing ovarian function and fertility following chemotherapy in premenopausal patients: Is there a role for ovarian suppression?
Kelsey A. Roof, Kerri E. Andre, Susan C. Modesitt, et al.
Gynecologic Oncology Reports (2024) Vol. 53, pp. 101383-101383
Open Access | Times Cited: 1
Endocrine health in survivors of adult-onset cancer
Cornelia S. Link, Andy Göbel, Nikolai Jaschke, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 5, pp. 350-364
Open Access | Times Cited: 1
Oncofertility as an Essential Part of Comprehensive Cancer Treatment in Patients of Reproductive Age, Adolescents and Children
Dominika Łubik-Lejawka, Iwona Gabriel, Adrianna Marzec, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1858-1858
Open Access | Times Cited: 1
Effectiveness of resistance training in preventing sarcopenia among breast cancer patients undergoing chemotherapy: A systematic review and meta‐analysis
Ting Wan Tan, Han Ling Tan, Yu‐Chu Chung
Worldviews on Evidence-Based Nursing (2024)
Open Access | Times Cited: 1
The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy
Laura Bornes, Lennart J. van Winden, Veerle Geurts, et al.
Nature (2024)
Open Access | Times Cited: 1
Does tamoxifen use increase the risk of endometrial cancer in premenopausal patients?
Versha Pleasant
OBG Management (2023) Vol. 35, Iss. 8
Open Access | Times Cited: 3
Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study
Çağlar Ünal, Çetın Ordu, Tolga Özmen, et al.
Current Oncology (2023) Vol. 30, Iss. 10, pp. 9217-9229
Open Access | Times Cited: 2
Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice
Adel I. Alalawy, Mohamed Sakran, Fahad Mohammed Alzuaibr, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Construction of esterase-responsive hyperbranched polyprodrug micelles and their antitumor activity in vitro
Jianxia Qiao, Shufen Li, Haoyu Yuan, et al.
e-Polymers (2022) Vol. 22, Iss. 1, pp. 513-521
Open Access | Times Cited: 3
Development of a digital anti-Müllerian hormone immunoassay: ultrasensitive, accurate and practical strategy for reduced ovarian reserve monitoring and assessment
Xiaojun Kuang, Liutong Wei, Yuanxin Huang, et al.
Talanta (2022) Vol. 253, pp. 123970-123970
Closed Access | Times Cited: 3
β-resorcylic acid released by Limosilactobacillus reuteri protects against cisplatin-induced ovarian toxicity and infertility
Yinglin Feng, Huimin Zheng, Chunhua Yin, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101678-101678
Open Access
Molecular Factors Predicting Ovarian Chemotoxicity in Fertile Women: A Systematic Review
Diego Raimondo, Antonio Raffone, Daniele Neola, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2793-2793
Open Access
Reproductive choice is supportive care in cancer
Niharika Dixit, Kari P. Braaten, Carolyn Taylor, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 4
Closed Access | Times Cited: 1
Association of serum reproductive hormones changes after neoadjuvant chemotherapy with hormone receptors expression alterations and survival outcomes in breast cancer
Ailin Lan, Yudi Jin, Yu Wang, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 2
Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy
Ailin Lan, Yudi Jin, Yu Wang, et al.
International Journal of Clinical Oncology (2022) Vol. 27, Iss. 5, pp. 899-910
Closed Access | Times Cited: 1
Fertility preservation options prior to gonadotoxic cancer treatment
Aysen Bilgicyildirim, Jutta Bratengeier, Hediel Engelskirchen-Amran
Die Gynäkologie (2023) Vol. 56, Iss. 6, pp. 427-432
Closed Access
Changes in the severity of chemotherapy-induced nausea and vomiting according to the menopausal stage of breast cancer patients during adjuvant chemotherapy: A prospective observational study
Chan‐Woo Yeom, Sang Il Lee, Seonmi Lee, et al.
Research Square (Research Square) (2023)
Open Access
Optionen des Fertilitätserhalts vor einer gonadotoxischen Therapie in der Onkologie
Aysen Bilgicyildirim, Jutta Bratengeier, Hediel Engelskirchen-Amran
Forum (2022) Vol. 38, Iss. 1, pp. 33-39
Closed Access
Schwangerschaft nach Krebs
Sibylle Loibl, Sabine Seiler
Forum (2022) Vol. 38, Iss. 1, pp. 22-27
Closed Access
Page 1 - Next Page

Scroll to top